POSB53 Healthcare Resource Utilization (HCRU) and Cost Studies in Patients Receiving First-Line (1L) Therapy for Advanced or Metastatic Urothelial Carcinoma (MUC): A Systematic Literature Review (SLR)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.326
https://www.valueinhealthjournal.com/article/S1098-3015(21)02121-5/fulltext
Title :
POSB53 Healthcare Resource Utilization (HCRU) and Cost Studies in Patients Receiving First-Line (1L) Therapy for Advanced or Metastatic Urothelial Carcinoma (MUC): A Systematic Literature Review (SLR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02121-5&doi=10.1016/j.jval.2021.11.326
First page :
Section Title :
Open access? :
No
Section Order :
11102